Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

4,728 total articles

RENN Fund Executive Adds to Personal Stake with $3,458 Purchase

RENN Fund Executive Adds to Personal Stake with $3,458 Purchase

Murray Stahl, President and Co-Portfolio Manager of RENN Fund, Inc. (RCG), purchased 1,154 shares on March 13, 2026, at $3.05 per share, bringing his direct holdings to 154,934 shares. The trades, executed at a level close to the fund's 52-week high, totaled $3,458. InvestingPro assigns RCG a financial health rating of "GOOD" and notes five additio…

Mill Road Capital Purchases $377,250 of Alta Equipment Shares

Mill Road Capital Purchases $377,250 of Alta Equipment Shares

Mill Road Capital III, L.P., together with Mill Road Capital III GP LLC and Thomas E. Lynch, bought a total of $377,250 worth of Alta Equipment Group Inc. (NASDAQ: ALTG) stock across two trading days in March 2026. The transactions bring Mill Road Capital III, L.P.'s direct holdings to 4,373,208 shares amid mixed analyst commentary and a recent ear…

Bankwell Director Executes $469,599 in Indirect Stock Purchases

Bankwell Director Executes $469,599 in Indirect Stock Purchases

On March 13, 2026, Bankwell Financial Group director Lawrence B. Seidman completed indirect purchases of company common stock totaling $469,599. The trades were executed through several affiliated entities at per-share prices between $46.95 and $46.99. The stock has returned 62.8% over the past year and traded at $47.83 following the purchases, a l…

Claritev EVP Michael Kim Buys $247,500 in Class A Shares

Claritev EVP Michael Kim Buys $247,500 in Class A Shares

Claritev Corp Executive Vice President and Chief Digital Officer Michael Kim reported a purchase of 15,000 Class A shares on March 12, 2026, spending $247,500 at $16.50 per share, according to a Form 4 filed with the SEC. The transaction increased Kim's direct holdings to 182,878 shares while the company's shares trade near a 52-week low after a st…

United Therapeutics CEO Disposes $5.1M in Shares, Executes Option Exercise as Company Advances Buyback and Clinical Data

United Therapeutics CEO Disposes $5.1M in Shares, Executes Option Exercise as Company Advances Buyback and Clinical Data

United Therapeutics Chairperson and CEO Martine Rothblatt sold $5.1 million worth of company common stock in two transactions on March 12 and March 16, 2026, at prices between $532.16 and $544.5849 per share. On March 16 she also exercised options to buy 9,500 shares at $146.03, for a total exercise cost of $1,387,285. The sales were carried out un…

Vivani Medical Director Increases Stake with $1.68M Purchase

Vivani Medical Director Increases Stake with $1.68M Purchase

Vivani Medical director Gregg Williams bought common stock in two separate trades on March 15, 2026, totaling about $1.68 million. The purchases followed a company financing that raised roughly $4.5 million and come as a Cortigent feasibility study reported positive safety and efficacy results for a visual cortical prosthesis.